Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer

This study was designed to evaluate the efficacy and tolerability of a weekly schedule of epirubicin in combination with docetaxel in the first-line treatment of patients with metastatic breast cancer (MBC). A total of 43 women with MBC not previously treated with chemotherapy for metastatic disease...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gamucci, T, D'Ottavio, A M, Magnolfi, E, Barduagni, M, Vaccaro, A, Sperduti, I, Moscetti, L, Belli, F, Meliffi, L
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2007
Schlagworte:
Clinical Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360453/
https://ncbi.nlm.nih.gov/pubmed/17940499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603982
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge